Jnana Therapeutics
上一次修改：2021年2月9日
生物技术
美国(美洲)
企业的 16 位主要高管 高管在Jnana Therapeutics变化
Nick Pullen已作为Senior Vice President and Head of Biology加入公司 (新闻发布的2021二月3号).
Brian Danieli已作为Vice President and Head of Finance & Operations加入公司 (新闻发布的2021二月3号).
Annie Chen已作为Director加入公司 (新闻发布的2021一月6号).
创建提醒
跟踪 Jnana Therapeutics 的高管变动
Jnana Therapeutics 搜索最多的简介
- Joanne Kotz, Director, President and Chief Executive Officer
- Margarita Chavez, Director
- Kevin Kinsella, Director
Latest M&A news in 生物技术.
Bio-Techne has acquired Asuragen (posted on 4月 7, 2021).
EQT has announced the acquisition of Cerba Healthcare (posted on 4月 1, 2021).
Everlywell has announced the acquisition of PWNHealth (posted on 3月 26, 2021).
生物技术 行业的其他推荐联系人
有关 Jnana Therapeutics 的最新新闻
Jnana Therapeutics Expands Leadership Team with Two Experienced Biopharmaceutical Executives • Jnana Therapeutics
Jnana Therapeutics Appoints Dr. Annie Chen to Board of Directors and Dr. Katalin Susztak to Scientific Advisory Board • Jnana Therapeutics
Roche, Jnana sign multi-target collaboration deal for small molecule drugs
News • Jnana Therapeutics
Jnana Therapeutics Enters Collaboration with Roche to Discover Novel Medicines that Target Key Regulators of Cellular Metabolism to Treat Immune-Mediated and Neurological Diseases • Jnana Therapeutics
Jnana Therapeutics 在 维基百科、谷歌新闻 和 雅虎财经
Jnana Therapeutics 在 LinkedIn、叽叽喳喳 和 YouTube
Jnana Therapeutics 拥有 1,632 家竞争者，其中包括 Biogen (美国(美洲))、Eurofins (法国) 和 Neptune Wellness Solutions (加拿大)。
